$134 Million is the total value of Lamond Capital Partners LLC's 10 reported holdings in Q3 2015. The portfolio turnover from Q2 2015 to Q3 2015 was 136.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AMGN | New | AMGEN INCcall | $20,748,000 | – | 150,000 | +100.0% | 15.53% | – |
| ORCL | New | ORACLE CORPcall | $18,060,000 | – | 500,000 | +100.0% | 13.52% | – |
| OCUL | Buy | OCULAR THERAPEUTIX INC | $17,340,000 | +15.9% | 1,233,285 | +73.3% | 12.98% | -14.6% |
| ALXN | Buy | ALEXION PHARMACEUTICALS INC | $15,639,000 | +52.8% | 100,000 | +76.6% | 11.70% | +12.7% |
| AMGN | Buy | AMGEN INC | $13,832,000 | -6.8% | 100,000 | +3.5% | 10.35% | -31.3% |
| ABBV | New | ABBVIE INCcall | $13,603,000 | – | 250,000 | +100.0% | 10.18% | – |
| GWPH | New | GW PHARMACEUTICALS PLCads | $10,964,000 | – | 120,000 | +100.0% | 8.20% | – |
| BMRN | New | BIOMARIN PHARMACEUTICAL INC | $10,532,000 | – | 100,000 | +100.0% | 7.88% | – |
| CY | New | CYPRESS SEMICONDUCTOR CORP | $9,372,000 | – | 1,100,000 | +100.0% | 7.01% | – |
| KITE | New | KITE PHARMA INCcall | $3,530,000 | – | 63,400 | +100.0% | 2.64% | – |
| BLCM | Exit | BELLICUM PHARMACEUTICALS INC | $0 | – | -68,780 | -100.0% | -1.48% | – |
| NVLS | Exit | NIVALIS THERAPEUTICS INC | $0 | – | -225,000 | -100.0% | -3.46% | – |
| BLOX | Exit | INFOBLOX INC | $0 | – | -230,872 | -100.0% | -6.14% | – |
| KITE | Exit | KITE PHARMA INC | $0 | – | -105,498 | -100.0% | -6.53% | – |
| HOSSQ | Exit | HORNBECK OFFSHORE SVCS INC N | $0 | – | -352,720 | -100.0% | -7.35% | – |
| VMEM | Exit | VIOLIN MEMORY INC | $0 | – | -3,934,580 | -100.0% | -9.79% | – |
| HPQ | Exit | HEWLETT PACKARD CO | $0 | – | -337,000 | -100.0% | -10.27% | – |
| AXGT | Exit | AXOVANT SCIENCES LTD | $0 | – | -692,961 | -100.0% | -14.34% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-11-09
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| INFOBLOX INC | 6 | Q2 2015 | 19.8% |
| AMGEN INC | 5 | Q4 2015 | 15.1% |
| OCULAR THERAPEUTIX INC | 5 | Q4 2015 | 19.3% |
| LINKEDIN CORP | 5 | Q3 2014 | 12.2% |
| FIDELITY NATL INFORMATION SV | 5 | Q2 2014 | 9.7% |
| MASTERCARD INC | 5 | Q2 2014 | 7.4% |
| GOOGLE INC | 4 | Q1 2014 | 12.0% |
| GW PHARMACEUTICALS PLC | 4 | Q4 2015 | 17.1% |
| SALESFORCE COM INC | 4 | Q4 2014 | 11.6% |
| INFORMATICA CORP | 4 | Q1 2014 | 9.1% |
View Lamond Capital Partners LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2016-07-19 |
| 13F-HR | 2016-05-05 |
| 13F-HR/A | 2016-02-09 |
| 13F-HR | 2016-02-09 |
| 13F-HR | 2015-11-09 |
| 13F-HR | 2015-08-07 |
| 13F-HR | 2015-05-12 |
| 13F-HR | 2015-02-13 |
| 13F-HR | 2014-11-07 |
| 13F-HR | 2014-08-06 |
View Lamond Capital Partners LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.